Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based Versus Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma

ObjectivesLobaplatin (LBP), a third-generation cisplatin derivative has shown promising activity and few side effects in oesophageal squamous cell carcinoma (ESCC) in previous reports. We compared LBP plus docetaxel with cisplatin plus docetaxel as adjuvant chemotherapy in ESCC patients to determine...

Full description

Bibliographic Details
Main Authors: Yan Zheng, Yin Li, Xianben Liu, Haibo Sun, Guanghui Liang, Jiajia Hu, Liping Li, Wenqun Xing
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Oncology
Subjects:
ESCC
adjuvant chemotherapy
lobaplatin
adverse reactions
cisplatin
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.668140/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.668140/full

Similar Items